These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22796337)

  • 1. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.
    Hasenour CM; Berglund ED; Wasserman DH
    Mol Cell Endocrinol; 2013 Feb; 366(2):152-62. PubMed ID: 22796337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK and the neuroendocrine regulation of appetite and energy expenditure.
    Stark R; Ashley SE; Andrews ZB
    Mol Cell Endocrinol; 2013 Feb; 366(2):215-23. PubMed ID: 22789749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding role of AMPK in endocrinology.
    Kola B; Boscaro M; Rutter GA; Grossman AB; Korbonits M
    Trends Endocrinol Metab; 2006 Jul; 17(5):205-15. PubMed ID: 16766204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK-dependent hormonal regulation of whole-body energy metabolism.
    Dzamko NL; Steinberg GR
    Acta Physiol (Oxf); 2009 May; 196(1):115-27. PubMed ID: 19245657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents.
    Huet C; Boudaba N; Guigas B; Viollet B; Foretz M
    J Biol Chem; 2020 May; 295(18):5836-5849. PubMed ID: 32184359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3).
    Handy JA; Saxena NK; Fu P; Lin S; Mells JE; Gupta NA; Anania FA
    J Cell Biochem; 2010 Aug; 110(5):1195-207. PubMed ID: 20564215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK and the endocrine control of energy metabolism.
    Steinberg GR
    Mol Cell Endocrinol; 2013 Feb; 366(2):125-6. PubMed ID: 23351885
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells.
    Luo Z; Zhang Y; Li F; He J; Ding H; Yan L; Cheng H
    Endocrine; 2009 Aug; 36(1):60-9. PubMed ID: 19440859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts.
    Schindler M; Pendzialek M; Grybel KJ; Seeling T; Gürke J; Fischer B; Navarrete Santos A
    Hum Reprod; 2017 Jul; 32(7):1382-1392. PubMed ID: 28472298
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
    [No Abstract]   [Full Text] [Related]  

  • 12. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
    Miyamoto L; Ebihara K; Kusakabe T; Aotani D; Yamamoto-Kataoka S; Sakai T; Aizawa-Abe M; Yamamoto Y; Fujikura J; Hayashi T; Hosoda K; Nakao K
    J Biol Chem; 2012 Nov; 287(48):40441-7. PubMed ID: 23024365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.
    Andreelli F; Foretz M; Knauf C; Cani PD; Perrin C; Iglesias MA; Pillot B; Bado A; Tronche F; Mithieux G; Vaulont S; Burcelin R; Viollet B
    Endocrinology; 2006 May; 147(5):2432-41. PubMed ID: 16455782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and lipid metabolism: key partners in energy balance.
    Varela L; Vázquez MJ; Cordido F; Nogueiras R; Vidal-Puig A; Diéguez C; López M
    J Mol Endocrinol; 2011 Apr; 46(2):R43-63. PubMed ID: 21169422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AMP-activated protein kinase--the key role in metabolic regulation].
    Jarzyna R
    Postepy Biochem; 2006; 52(3):283-8. PubMed ID: 17201063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
    Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
    Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the AMP-activated protein kinase in the regulation of energy homeostasis.
    Carling D
    Novartis Found Symp; 2007; 286():72-81; discussion 81-5, 162-3, 196-203. PubMed ID: 18269175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process.
    Salminen A; Kauppinen A; Kaarniranta K
    J Mol Med (Berl); 2017 Feb; 95(2):123-131. PubMed ID: 27678528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.
    Aw DK; Sinha RA; Xie SY; Yen PM
    Biochem Biophys Res Commun; 2014 May; 447(4):569-73. PubMed ID: 24735537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.